| Name | Title | Contact Details |
|---|
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Carbon Health is a modern, tech-enabled healthcare company transforming the primary care, urgent care, and virtual care experience. With a team of expert physicians, engineers, and designers, Carbon Health pushes the boundaries of medicine to deliver personal, accessible and high quality care. We aim to give patients connection to their medical records, quick access for immediate and ongoing healthcare needs, and a network of healthcare experts. We want patients to feel as though they have an advocate - like a doctor in their family. With a growing network of trusted clinics, and an end-to-end platform that supports ongoing care management and virtual appointments, Carbon Health ensures world-class care is affordable and always in reach.
United Insurance Services Ltd is a Oak Lawn, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Windham Terrace is a Windham, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We aim to advance urologic patient care through bold innovation, based on diversity of thought, openness to new ideas, adaptation to change, integrity and compassion. We develop innovative therapies and participate in exceptional licensing opportunities. Our goal is to be the leading specialty company: recognized and trusted by patients and providers for our commitment to urology. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated.